Edinburgh-based Craneware, a software firm that specializes in the US healthcare market, said its revenue increased 16% to $31.1 million and profit before tax increased 16% to $8.7 million in the six months to December 31, 2017.

Proposed interim dividend is increased 15% to 10p per share.

In its outlook, Craneware said it has a record sales pipeline for the current financial year, with “total visible revenue of over $63.1 million for the current financial year …”

Craneware CEO Keith Neilson said: “Our extensive expertise and experience in the US healthcare market means we are well positioned to provide actionable insight for our customers.

“By combining their financial and operational data in unique ways, our solutions ensure they can continue to thrive in the new era of value-based care.

“The investments made into Craneware’s product suite and operations in recent years means we are now delivering growth rates which are outperforming our industry.

“We are seeing growing interest across our enlarged product suite and are particularly pleased with the high levels of interest and opportunities across our customer base for our newly launched cloud-based platform, Trisus.

“With an ongoing, growing market opportunity, a record sales pipeline and increasing long-term revenue visibility, we enter the second half of the year with great confidence for the future and the ongoing success of the business.”